These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35597526)

  • 1. The potential impact of CYP2D6 (*2/*4/*10) gene variants among Egyptian epileptic children: A preliminary study.
    Elsaid AM; Zahran RF; Elmetwaly SM; Wahba Y; Megahed H; Elshazli RM
    Gene; 2022 Jul; 832():146585. PubMed ID: 35597526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy.
    López-García MA; Feria-Romero IA; Serrano H; Rayo-Mares D; Fagiolino P; Vázquez M; Escamilla-Núñez C; Grijalva I; Escalante-Santiago D; Orozco-Suarez S
    Pharmacol Rep; 2017 Jun; 69(3):504-511. PubMed ID: 28343093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of genetic polymorphisms of cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in Turkish children.
    Seven M; Batar B; Unal S; Yesil G; Yuksel A; Guven M
    Mol Diagn Ther; 2014 Apr; 18(2):229-36. PubMed ID: 24338437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities.
    Bagheri A; Kamalidehghan B; Haghshenas M; Azadfar P; Akbari L; Sangtarash MH; Vejdandoust F; Ahmadipour F; Meng GY; Houshmand M
    Drug Des Devel Ther; 2015; 9():2627-34. PubMed ID: 25999696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN).
    Atanasova SY; von Ahsen N; Toncheva DI; Dimitrov TG; Oellerich M; Armstrong VW
    Clin Biochem; 2005 Mar; 38(3):223-8. PubMed ID: 15708542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variability of
    Mutawi TM; Zedan MM; Yahya RS; Zakria MM; El-Sawi MR; Gaedigk A
    Pharmacogenomics; 2021 Apr; 22(6):323-334. PubMed ID: 33789449
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.
    Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A
    Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
    Skadrić I; Stojković O
    Int J Legal Med; 2020 Mar; 134(2):433-439. PubMed ID: 31858263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of human cytochrome P450 CYP2D6 gene.
    Steen VM; Molven A; Aarskog NK; Gulbrandsen AK
    Hum Mol Genet; 1995 Dec; 4(12):2251-7. PubMed ID: 8634695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2C9 (*2&*3) and CYP2C19 (*2&*3) polymorphisms among children with nonlesional epilepsy: a single-center study.
    Eltalal S; El Ayouty M; El-Said A; Wahba Y
    Acta Neurol Belg; 2021 Dec; 121(6):1623-1631. PubMed ID: 32683556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of SCN2A c.56G/A Gene Polymorphism in Egyptian Children with Genetic Epilepsy with Febrile Seizure Plus.
    Berseem NF; Khattab ESAEH; Saad DS; Abd Elnaby SA
    CNS Neurol Disord Drug Targets; 2022; 21(5):450-457. PubMed ID: 34607551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 2D6 and glutathione S-transferase M1 genotypes and migraine.
    Mattsson P; Bjelfman C; Lundberg PO; Rane A
    Eur J Clin Invest; 2000 Apr; 30(4):367-71. PubMed ID: 10759887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
    Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
    Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children.
    Abo El Fotoh WM; Abd El Naby SA; Habib MS; ALrefai AA; Kasemy ZA
    Seizure; 2016 Oct; 41():75-80. PubMed ID: 27498208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population.
    Garcia-Barceló M; Chow LY; Chiu HF; Wing YK; Lee DT; Lam KL; Waye MM
    Clin Chem; 2000 Jan; 46(1):18-23. PubMed ID: 10620567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis.
    Haerian BS; Roslan H; Raymond AA; Tan CT; Lim KS; Zulkifli SZ; Mohamed EH; Tan HJ; Mohamed Z
    Seizure; 2010 Jul; 19(6):339-46. PubMed ID: 20605481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CYP2D6*3 and 2D6*4 allelic variants by PCR-restriction fragment length polymorphism.
    Topić E; Stefanović M; Nikolić V; Zoricić I; Ivanisević AM; Zuntar I
    Clin Chem Lab Med; 1998 Aug; 36(8):655-8. PubMed ID: 9806480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and structural characterisation of common cytochrome P450 2D6 allelic variants-roles of Pro34 and Thr107 in catalysis and inhibition.
    Dong AN; Ahemad N; Pan Y; Palanisamy UD; Yiap BC; Ong CE
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):1015-1029. PubMed ID: 31025144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.